GGrantIndex
Sort

326,823 grants matching clinical trial

Biodefense/Emerging Infection Vaccine Studies

$2,065,989
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Preserving Renal Function & Protective Immunity Via Anti-LFA1-Based CNI Avoidance

$2,065,943
Christian P Larsen · Emory University · U01 · FY2010 · AI

Biology & Transplantation of the Human Stem Cell

$2,065,942
Philip McGlave · University Of Minnesota · P01 · FY2007 · CA

Integrative Oncogenomics of Multiple Myeloma

$2,065,928
Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2019 · CA

Integrative Oncogenomics of Multiple Myeloma

$2,065,928
Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2021 · CA

Integrative Oncogenomics of Multiple Myeloma

$2,065,928
Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2020 · CA

Integrative Oncogenomics of Multiple Myeloma

$2,065,928
Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2018 · CA

Targeted Clinical Research Program to Address Selected Viral Infections

$2,065,894
Richard Whitley · University Of Alabama At Birmingham · N01 · FY2011 · AI

SPORE in Breast Cancer

$2,065,692
Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2007 · CA

GENERAL CLINICAL RESEARCH CENTER

$2,065,651
University Of Texas Medical Br Galveston · M01 · FY2000 · RR

1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)

$2,065,518
Joseph Eric Levitt · Stanford University · UH3 · FY2020 · HL

Functional Omics Core Laboratory

$2,065,495
Steven Edward Bosinger · Emory University · N01 · FY2025 · AI

Phase III Study of a Nicotine Vaccine for Smoking Cessation

$2,065,470
Paul D Kessler · Nabi Biopharmaceuticals · RC2 · FY2010 · DA

BIOLOGY AND GENETICS OF MARROW ALLOGRAFTS FOR LEUKEMIA

$2,065,351
Sloan-Kettering Institute For Cancer Res · P01 · FY2000 · CA

Mechanisms of Cellular Responses to Ionizing Radiation

$2,065,280
Anatoly Dritschilo · Georgetown University · P01 · FY2006 · CA

NYU Melanoma SPORE

$2,065,182
Iman Osman · New York University School Of Medicine · P50 · FY2021 · CA

Advancing the Development of a Humanized Anti-cocaine Monoclonal Antibody

$2,065,159
Andrew B Norman · University Of Cincinnati · U01 · FY2016 · DA

Biomarkers of Developmental Trajectories and Treatment in ASD

$2,065,152
Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2012 · HD

The Military HIV Research Program (MHRP) Clinical Trial Unit

$2,065,103
Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2023 · AI

Washington University SPORE in Pancreatic Cancer

$2,065,042
David G Denardo · Washington University · P50 · FY2023 · CA

Plasma metabolite and proteome signatures for migraine classification

$2,065,041
Daniel Ian Chasman · Brigham And Women'S Hospital · R61 · FY2021 · NS

COHORT STUDY OF DIETARY SUPPLEMENTS AND CANCER RISK

$2,065,030
Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA

Understanding mechanisms and seeking novel biomarkers in Alzheimer's disease

$2,064,916
Madhav Thambisetty · National Institute On Aging · ZIA · FY2021 · AG

New Approaches to Gene Therapy for Alpha-1 Antitrypsin Deficiency

$2,064,892
Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2017 · HL

Biomarkers of Developmental Trajectories and Treatment in ASD

$2,064,883
Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2015 · HD